Evidence map›Paper›PMID 38948061›Full record

ArticleTheranostics2024

Enhancing precision: A predictive model for

Azadeh Akhavanallaf, Sonal Joshi, Arathi Mohan, Francis P Worden, John C Krauss, Habib Zaidi, Kirk Frey, Krithika Suresh, Yuni K Dewaraja, Ka Kit Wong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Frontiers in endocrinology · 2026
    Pooled it
  2. Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  3. Review
  4. Combination therapy strategies in engineeredCell communication and signaling : CCS · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Azadeh AkhavanallafDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Sonal JoshiDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Arathi MohanDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Francis P WordenDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
John C KraussDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Habib ZaidiDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, CH-1211 Geneva, Switzerland.
Kirk FreyDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Krithika SureshDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Yuni K DewarajaDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.
Ka Kit WongDepartment of Radiology, University of Michigan, Ann Arbor, MI, USA.

Funding

Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine ClinicR01CA240706 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2020 to 2024
$3.0M
NCI NIH HHS R01 CA240706
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorNeuroendocrine TumorsOctreotideOrganometallic CompoundsAdultAgedAged, 80 and overAlkaline PhosphataseChromogranin AFemaleHumansKi-67 AntigenMaleMiddle AgedPositron-Emission TomographyProgression-Free SurvivalAlkaline PhosphataseBiomarkers, TumorChromogranin Agallium Ga 68 dotatateKi-67 Antigenlutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadiopharmaceuticalsReceptors, Somatostatinimages-based featuresNEToutcome predictionPRRTSSTR-PET

Identifiers

PMID38948061
PMCPMC11209719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.